Rapport Therapeutics, Inc. (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

46.98

+1.49 (3.28%)

At close: Aug 10, 2026, 4:00 PM EDT

47.30

+0.32 (0.68%)

After-hours: Aug 10, 2026, 4:18 PM EDT

Rapport Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	63.61	52.65	56.81	70.17
Short-Term Investments	372.47	437.89	248.48	77.31
Cash & Short-Term Investments	436.08	490.54	305.28	147.48
Cash Growth	67.43%	60.69%	107.00%	-
Accounts Receivable	0.29	-	-	-
Other Current Assets	10.49	8.02	4.52	3.39
Total Current Assets	446.86	498.56	309.8	150.87
Net Property, Plant & Equipment	11.07	12.89	4.97	4
Other Long-Term Assets	1.06	0.99	0.16	0.55
Total Assets	458.98	512.43	314.93	155.42
Accounts Payable	2.8	4.19	1.95	2.5
Accrued Expenses	23.16	12.1	6.08	5.63
Current Portion of Leases	2.47	2.76	0.74	0.67
Total Current Liabilities	28.42	19.05	8.77	8.8
Long-Term Leases	7.63	8.73	0.74	1.48
Other Long-Term Liabilities	-	-	-	4.2
Total Long-Term Liabilities	7.63	8.73	0.74	5.68
Total Liabilities	36.06	27.78	9.51	14.48
Common Stock	0.05	0.05	0.04	0
Additional Paid-in Capital	735.85	719.29	429.66	19.8
Accumulated Other Comprehensive Income	-1.27	0.55	-0.52	0
Retained Earnings	-311.7	-235.23	-123.75	-45.44
Total Common Shareholders' Equity	422.93	484.65	305.43	-25.63
Minority Interest	-	-	-	166.58
Shareholders' Equity	422.93	484.65	305.43	140.94
Total Liabilities & Equity	458.98	512.43	314.93	155.42
Total Debt	10.11	11.48	1.48	2.15
Net Cash (Debt)	425.97	479.06	303.8	145.33
Net Cash Growth	71.36%	57.69%	109.04%	-
Net Cash Per Share	9.49	12.30	14.65	96.52
Book Value	422.93	484.65	305.43	-25.63
Book Value Per Share	9.42	12.45	14.73	-17.02
Tangible Book Value	422.93	484.65	305.43	-25.63
Tangible Book Value Per Share	9.42	12.45	14.73	-17.02

SEC Filings: 10-K · 10-Q